Titelia

Holdings of Caligan Partners LP

· Original filing · Compare with another fund · Report an error

Net assets
-
Positions
23 in 2 countries
Top ten
80.9 % of the equity sleeve
Filed on
Mar 31, 2026
Portfolio shape

Positions

RankCompanySharesValueWeight
1Liquidia Corp 8,118,892306.4M $
2ABIVAX SA 1,461,924162.8M $
3REVOLUTION MEDICINES INC 1,652,808160.7M $
4VAXCYTE INC 2,060,719119.7M $
5Mineralys Therapeutics Inc 2,772,65475.1M $
6Exelixis Inc 1,553,26266.6M $
7Tango Therapeutics Inc 2,408,79850.4M $
8TYRA BIOSCIENCES INC 1,276,96848.9M $
9Spyre Therapeutics Inc 878,12744.3M $
10ADMA Biologics Inc 4,756,51142.9M $
11LB Pharmaceuticals Inc 1,438,07034.6M $
12VOR BIOPHARMA INC 1,925,06634.3M $
13SAB Biotherapeutics Inc 7,967,20730.5M $
14Opus Genetics Inc 6,075,02827.6M $
15INVENTIVA SA 4,974,90627.6M $
16MBX BIOSCIENCES INC 848,59025.3M $
17AVALO THERAPEUTICS INC 1,635,02324.4M $
18Anika Therapeutics Inc 1,435,13020.8M $
19Maze Therapeutics Inc 614,96218.4M $
20Verrica Pharmaceuticals Inc 923,9104.9M $
21SENSEI BIOTHERAPEUTICS INC 126,0024M $
22Aura Biosciences Inc 229,8641.5M $
23Xilio Therapeutics Inc 112,128943K $

Download this table: CSV, JSON

Tell me about updates

Sector breakdown

  • Unattributed 100.0 %

Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".

Currency breakdown

  • USD 100.0 %

Each line is counted in its quoted currency, as the fund declares it.

Country breakdown

  • United States 85.7 %
  • France 14.3 %

Shares are computed on the fund's equities only.

RankCountryLinesValueShare
1United States211.1B $85.72 %
2France2190.4M $14.28 %
Cite this page

Titelia. "Holdings of Caligan Partners LP". https://titelia.com/en/funds/US13F1727492